Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 4.92 AUD 3.14% Market Closed
Market Cap: 418.6m AUD
Have any thoughts about
Mayne Pharma Group Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

-1.8
Current
-3.2
Median
16.6
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-1.8
=
Enterprise Value
283.1m AUD
/
EBIT
-155.3m AUD
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-12.7
2-Years Forward
EV/EBIT
-148.6
3-Years Forward
EV/EBIT
9.9

See Also

Discover More